Comparison of aortoiliac disease stenting patency using balloon-expandable, self-expanding, and covered stents - Summary - MDSpire

Comparison of aortoiliac disease stenting patency using balloon-expandable, self-expanding, and covered stents

  • By

  • Ali A. Hasnie

  • Tonga Nfor

  • James O. Adefisoye

  • Kelly Magee

  • M. Fuad Jan

  • Mark W. Mewissen

  • Tanvir K. Bajwa

  • Babak Haddadian

  • May 13, 2026

Share

Objective:

To investigate patency rates of balloon-expandable, self-expanding, and covered stents in patients with aortoiliac artery disease using a large international database, focusing on real-world data.

Key Findings:
  • 58% of stents implanted were balloon-expandable stents.
  • One-year primary patency rates: balloon-expandable stents (98.4%), self-expanding stents (97.1%), covered stents (96.3%) (P = 0.03).
  • No significant difference in 3-year primary patency rates among stent types (P = 0.17).
  • Overall technical success rate was excellent in all three stent groups (>99%).
Interpretation:

Stent selection for aortoiliac PAD interventions should prioritize cost, lesion characteristics, operator judgment, and other relevant factors rather than relying solely on long-term patency outcomes.

Limitations:
  • Retrospective design may introduce selection bias.
  • Exclusion of patients with prior interventions may limit generalizability; specific types of prior interventions excluded should be noted.
Conclusion:

Contemporary data indicate no meaningful correlation between stent type and 3-year primary patency in aortoiliac PAD interventions.

Original Source(s)

Related Content